⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4666244 | 0.80 | — | — | |
| SCHEMBL28481306 | 0.70 | — | — | |
| SCHEMBL7339263 | 0.66 | — | — | |
| SCHEMBL19260288 | 0.64 | — | — | |
| SCHEMBL4777648 | 0.62 | CHRM2 (0.30) | — | |
| SCHEMBL374736 | 0.57 | — | — | |
| Iodide SCHEMBL9138242 | 0.56 | — | — | |
| Hydrogen Sulfide SCHEMBL28208143 | 0.56 | — | — | |
| Hydrochloric Acid SCHEMBL7828243 | 0.56 | — | — | |
| SCHEMBL22518581 | 0.53 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116848125-A | H4 antagonist compounds | 赫帕雷斯治疗有限公司 | 2023-10-03 | — | — | CN | claimed |
| EP-2155757-A1 | NEW PROGESTERONE RECEPTOR MODULATORS | N.V. Organon (NL) | 2010-02-24 | — | — | EP | claimed |
| WO-2008135291-A1 | NEW PROGESTERONE RECEPTOR MODULATORS | N.V. ORGANON (NL) | 2008-11-13 | — | — | WO | claimed |
| EP-3846903-B1 | BICYCLIC HETEROARYL DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2023-10-25 | — | — | EP | disclosed |
| CN-116848125-A | H4 antagonist compounds | 赫帕雷斯治疗有限公司 | 2023-10-03 | — | — | CN | disclosed |
| US-10253042-B2 | N-(2-(2-amino-6-substituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]oxazin-8a(8H)-YL)-thiazol-4-YL) amides | PFIZER INC. (US) | 2019-04-09 | — | — | US | disclosed |
| EP-3353182-A1 | TETRAHYDROPYRANO[3,4-D][1,3]OXAZIN DERIVATIVES AND THEIR USE AS BACE INHIBITORS | Pfizer Inc (US) | 2018-08-01 | — | — | EP | disclosed |
| US-20170369506-A1 | N-(2-(2-AMINO-6-SUBSTITUTED-4,4a,5,6-TETRAHYDROPYRANO[3,4-d][1,3]OXAZIN-8a(8H)-YL)-THIAZOL-4-YL) AMIDES | PFIZER INC. (US) | 2017-12-28 | — | — | US | disclosed |
| US-9771379-B2 | N-(2-(2-amino-6-substituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]OXAZIN-8a(8H)-yl)-thiazol-4-yl) amides | PFIZER INC. (US) | 2017-09-26 | — | — | US | disclosed |
| WO-2017051303-A1 | TETRAHYDROPYRANO[3,4-D][1,3]OXAZIN DERIVATIVES AND THEIR USE AS BACE INHIBITORS | PFIZER INC. (US) | 2017-03-30 | — | — | WO | disclosed |
| US-20170088556-A1 | N-(2-(2-AMINO-6-SUBSTITUTED-4,4a,5,6-TETRAHYDROPYRANO[3,4-d][1,3]OXAZIN-8a(8H)-YL)-THIAZOL-4-YL) AMIDES | PFIZER INC. (US) | 2017-03-30 | — | — | US | disclosed |
| EP-2155757-A1 | NEW PROGESTERONE RECEPTOR MODULATORS | N.V. Organon (NL) | 2010-02-24 | — | — | EP | disclosed |
| WO-2008135291-A1 | NEW PROGESTERONE RECEPTOR MODULATORS | N.V. ORGANON (NL) | 2008-11-13 | — | — | WO | disclosed |